title: Targeted mutagenesis of sigma54 activator proteins in Myxococcus xanthus.
abstract: Myxococcus xanthus DNA segments related to the highly conserved central sequence of sigma54 activator proteins have been investigated. A genetic technique designed to inactivate a gene that encodes such an activator by inserting a plasmid-borne internal fragment of the putative gene has been tested. When the internal fragment inserted by homologous recombination into the corresponding chromosomal locus, the expected duplication of the gene was observed by Southern hybridization. The single restriction fragment characteristic of each segment was replaced in the insertion strains by two hybridizing fragments, and one of these fragments hybridized with the kanamycin resistance gene of the plasmid vector. The combined molecular weights of the two fragments from the insertion strains were equal to the molecular weight of the original fragment plus the expected molecular weight contributed by the vector. In the duplication, one copy is expected to have an N-terminal deletion and the other copy is expected to have a C-terminal deletion. In most cases, the net result should be loss of activator function. If an activator is essential for vegetative growth, then it should not be possible to obtain the insertion strain by plasmid integration. Indeed, integrants for three of the segments were not obtained in repeated trials; however, a plausible explanation for these results other than lethality can be offered. Of the seven insertions validated by Southern hybridization, four strains exhibited defects in the development of fruiting bodies. One of these failed to develop in submerged culture, though it developed normally on agar. The other three showed arrested development of fruiting bodies, each at a morphologically different stage of aggregation. One of the mutants may be defective in the reception pathway of A-signal.
authors.affiliation: Department of Biochemistry and Department of Developmental Biology, Stanford University School of Medicine, Stanford, California 94305-5329, USA.
authors.forename: L
authors.initials: L
authors.lastname: Gorski
authors.forename: D
authors.initials: D
authors.lastname: Kaiser
mesh_terms: D001426:Bacterial Proteins; D004268:DNA-Binding Proteins / Q000235:genetics* / Q000502:physiology; D012321:DNA-Directed RNA Polymerases / Q000235:genetics* / Q000502:physiology; D018390:Gene Targeting; D017930:Genes, Reporter; D016296:Mutagenesis; D016941:Myxococcus xanthus / Q000235:genetics* / Q000254:growth & development / Q000502:physiology; D051922:PII Nitrogen Regulatory Proteins; D051877:RNA Polymerase Sigma 54; D012808:Sigma Factor / Q000235:genetics* / Q000502:physiology; D013171:Spores, Bacterial; D015534:Trans-Activators; D014157:Transcription Factors / Q000235:genetics* / Q000502:physiology
chemical_list: D001426:Bacterial Proteins; D004268:DNA-Binding Proteins; D051922:PII Nitrogen Regulatory Proteins; D012808:Sigma Factor; D015534:Trans-Activators; D014157:Transcription Factors; D012321:DNA-Directed RNA Polymerases; D051877:RNA Polymerase Sigma 54